Skip to content Skip to footer
Insights+ Key Biosimilars Events of October 2019

Insights+ Key Biosimilars Events of October 2019

Biosimilars are key alternatives for costly Biologics therapies and saving millions of dollars of patients in multiple diseases. Hence physicians are likely to adopt biosimilars 'a reference product to biologics'possessing similar therapeutic properties in terms of potency, safety, and efficacy to original biologic products. Our team at PharmaShots has summarized key events of the biosimilar…

Read more

Generics Pharma Companies Top 20 2018

Top 20 Generics Pharma Companies Based On 2018 Revenue

The global generics pharmaceutical market is continuously growing and increasing with its accessibility & benefits offered as efficient and economical drugs- are always needed in the market. Generics are approved copies of small molecule drugs which contain the same amount of active ingredients- dosage form- safety- strength- route of administration- quality- performance characteristics- as of…

Read more

Insights+ Key Biosimilars Events of August 2019

Insights+ Key Biosimilars Events of August 2019

Biosimilars are key alternatives for costly Biologics therapies and saving million dollars of patients in multiple diseases. Hence physicians are likely to adopt biosimilars a reference product to biologics possessing similar therapeutic properties in terms of potency, safety, and efficacy to original biologic products. Our team at PharmaShots has summarized key events of biosimilar space…

Read more

Sign Up to Our Newsletter

Be the first to know the latest updates

[mc4wp_form id="13387" element_id="style-1"]